life sciences
Industries

Life Sciences Strategy

For 25 years, our global team of senior experts has helped Life Science firms anticipate trends and break through strategic barriers. CRA’s fit-for-purpose designs go beyond a single project, to build a true strategic partnership, providing cross-functional support across industry stakeholders and geographies. Clients rely on CRA’s institutional knowledge and subject matter expertise to provide an independent perspective to address core business issues, drive change, and align internal stakeholders.

Our Focus Areas

Comprehensive strategic expertise

We help clients address challenges in four key areas of strategy.

  • Pipeline Planning
    Discover
    • White Space Analysis
    • Market & Competitor Landscaping
    • Indication Prioritization & Sequencing
    • Opportunity Assessment
    • Buying Process & Leverage Points
    • Asset Go/No-Go Decision Making
    • BD, Licensing & Divestment
  • Building on proof-of-concept
    Develop
    • Value Proposition / Early Positioning
    • Evidence Generation Planning & Strategy
    • Forecasting & Scenario Planning
    • Patient Journey & Flow Analysis
    • Market Sizing & Mapping
    • KOL Influence / Stakeholder Segmentation
    • Pricing & Reimbursement Assessment
  • Deliver
    Optimizing launch
    • Launch Strategy & Go-to-Market Model
    • Demand & Market Activation
    • Patient Finding
    • Stakeholder Engagement & Value Communication
    • Pricing & Contracting Strategy
    • Launch Execution Guidance
    • KPIs & Launch Dashboard
  • Lifecycle and LOE
    Defend
    • Launch Assessment & Monitoring
    • Growth Strategy
    • Lifecycle Management
    • Competitor Defense Strategy
    • Real World Evidence Generation
    • Portfolio Strategy

Engagements

  • 01
    Pan-tumor communication strategy in oncology
    Client Issue Our client was preparing to expand its indication across multiple tumor types and wanted to develop a strategy for a single campaign that could be...
    View engagement
  • 02
    Understanding and segmenting a rare disease market
    Client Issue Our client sought to develop a better understanding of the market for a rare disease, including patient diversity and treatment, in anticipation...
    View engagement
  • 03
    Developed go-to-market strategy for follow-on asset with blockbuster potential
    Client Issue Our client sought to develop an “agile launch” approach to commercialize its second-generation diabetes asset considering competitor pressures and...
    View engagement

Meet our team

Subscribe to receive our latest Insights.

Subscribe